Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
2016 · ACS Chemical Biology · 587 citations
https://doi.org/10.1021/acschembio.6b00651
Z
Zhuyin Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
3.4K
Citations
27
h-index
39
i10-index
Zhuyin Li is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Receptor Mechanisms and Signaling & Cardiac Valve Diseases and Treatments & Cell Image Analysis Techniques. The author has an h-index of 27, co-authored 107 publications.
Papers by this author
worksClinical Phenogroups in Heart Failure With Preserved Ejection Fraction
2020 · JACC Heart Failure · 376 citations
https://doi.org/10.1016/j.jchf.2019.09.009
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
2020 · Journal of the American College of Cardiology · 204 citations
https://doi.org/10.1016/j.jacc.2019.12.069
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
2015 · Nature Communications · 176 citations
https://doi.org/10.1038/ncomms7220
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
2016 · Journal of Biological Chemistry · 146 citations
https://doi.org/10.1074/jbc.m116.738567
Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates
2025 · Molecular Therapy — Methods & Clinical Development · 6 citations
https://doi.org/10.1016/j.omtm.2025.101411
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat